Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000644537 | SCV000766237 | benign | Hypercholesterolemia, autosomal dominant, 3 | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000771236 | SCV000903335 | benign | Familial hypercholesterolemia | 2018-09-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001592794 | SCV001824637 | likely benign | not provided | 2019-10-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002406407 | SCV002717134 | likely benign | Cardiovascular phenotype | 2018-02-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003117450 | SCV003801301 | benign | not specified | 2023-01-09 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001592794 | SCV004222371 | benign | not provided | 2023-03-21 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001592794 | SCV004564247 | benign | not provided | 2023-09-20 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000644537 | SCV004844465 | benign | Hypercholesterolemia, autosomal dominant, 3 | 2024-02-05 | criteria provided, single submitter | clinical testing |